Novo Nordisk has been looking to diversify its lineup in recent years, and is developing medicines in other fields. The ...

Novo Nordisk (NVO) stock took a hit this week, after a Super Bowl ad highlighted a growing challenge to the company’s ...

The biosimilars reach the US market as the US insulin space has seen seismic changes in the last few years, with a clamour of ...

While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...

Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

Glucagon-like peptide receptor agonists (GLP-1RAs) like Novo Nordisk’s semaglutide (Ozempic, Wegovy) and Eli Lilly’s ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

FDA approves third insulin biosimilar Merilog to ease U.S. supply shortage FDAs latest insulin biosimilar approval aims to mitigate ongoing supply challenges in the U.S.

Between 2018 and 2024, China has launched 188 domestically developed innovative drugs – nearly double the number from the ...

Healthcare costs and spending have been rising in the US. The Centers for Medicare & Medicaid Services reported that ...